Synendos Therapeutics AG is a biopharmaceutical company founded in April 2019 as a spin-off of the University of Bern.
Synendos develops an innovative therapeutic approach based upon first-in-class inhibitors (small molecules) that modulate a new drug target (not yet published). The inhibitors were designed and developed at the University of Bern starting from an in silico screening of 12 million compounds which was followed by a thorough med chem programme in collaboration with a CRO.
The inhibitors act with a new mechanism of action that enables restoration of the natural function of the brain by rebalancing altered neurotransmission in different areas of the bran.
Our mission is to develop breakthrough safe and effective therapies for unmet needs in neuropsychiatric disorders.
Synendos develops an innovative therapeutic approach based upon first-in-class inhibitors (small molecules) that modulate a new drug target (not yet published). The inhibitors were designed and developed at the University of Bern starting from an in silico screening of 12 million compounds which was followed by a thorough med chem programme in collaboration with a CRO.
The inhibitors act with a new mechanism of action that enables restoration of the natural function of the brain by rebalancing altered neurotransmission in different areas of the bran.
Our mission is to develop breakthrough safe and effective therapies for unmet needs in neuropsychiatric disorders.
Location: Switzerland, Basel-Landschaft, Allschwil
Employees: 1-10
Total raised: $69.76M
Founded date: 2019
Investors 5
| Date | Name | Website |
| 10.06.2024 | Venture Ki... | venturekic... |
| - | Ysios Capi... | ysioscapit... |
| - | VentureLab | venturelab... |
| 13.11.2020 | Kurma Part... | kurmapartn... |
| - | High-Tech ... | htgf.de |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 21.04.2021 | Series A | $26.14M | - |
| 12.11.2020 | Series A | $21.86M | - |
| 12.11.2020 | Series A | $21.77M | - |
Mentions in press and media 28
| Date | Title | Description |
| 31.10.2025 | More than 20 Swiss biotech companies to exhibit at Bio Europe | Bio-Europe, the leading partnering conference for the global biotechnology industry, is held annually to connect biotech, pharma, investors, and service providers through one-to-one meetings, presentations, and panels. It serves as a leadi... |
| 02.10.2025 | Life sciences companies make positive progress | At Synendos Therapeutics, topline results of the phase 1 clinical trial for its lead asset, SYT-510, a first-in-class inhibitor that modulates a newly identified drug target in the Endocannabinoid System that helps restore healthy brain fu... |
| 01.09.2025 | New Startup Innovation Projects set to advance their technologies | With the Startup innovation projects support offer, Innosuisse directly funds high potential science-based projects initiated by Swiss startups, giving them a financial boost to propel their market entry. The innovative projects must be ba... |
| 14.08.2025 | Four startups welcome new leaders to accelerate growth | Effective this month, Woody Schoch is the new CEO at Alivion, the developer of a science-backed solution, Nutrion, a precise breath analyzer to measure the current status of fat burning. With a simple breath, the device analyses specific b... |
| 18.03.2025 | Swiss Economic Awards: Finalisten sind bekannt | Der Swiss Economic Award zählt zu den wichtigsten Preisen für Jungunternehmen der Schweiz. Der Award prämiert herausragende unternehmerische Leistungen in den Kategorien Dienstleistung, Deeptech/Lifesciences und Produktion/Gewerbe. Nun hat... |
| 08.11.2024 | Bio-Europe: Switzerland's Biotech Showcase in Stockholm | The heart of Europe beats strong in Stockholm this November. Bio-Europe, the continent's premier partnering event for the life sciences, is back for its 30th edition. This year, it promises to be a melting pot of innovation, collaboration, ... |
| 05.11.2024 | Bio Europe in Stockholm hosts 33 Swiss companies | Currently in its 30-year-edition, BIO-Europe remains Europe's leading partnering event, for the life sciences ecosystem, providing an exceptional opportunity to explore the latest trends learn and connect with potential partners. The past ... |
| 31.05.2024 | Swiss life science startups headed for San Diego | The BIO International Convention 2024, taking place in San Diego from 3 to 6 June, is the largest global biotechnology event with over 20,000 industry leaders from around the world attending. The target group includes representatives from ... |
| 22.01.2024 | Synendos Therapeutics’ drug against CNS disorders cleared for clinical trials | |
| 05.06.2023 | A significant number of Swiss biotechs exhibit in Boston |
Show more